This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Investigation of differences between primary studies
Not specified.
Results of the review
The carrier detection rate for both screening strategies was taken to be 80% and the uptake for women offered screening was 75%.
Methods used to derive estimates of effectiveness
In the absence of published data, the authors made baseline assumptions regarding carrier status, the uptake rate of prenatal diagnosis and the uptake for partners of carrier women.
Estimates of effectiveness and key assumptions
It was assumed that carrier couples remember their status, but otherwise 20% having missing information and of the remainder, 20% change partners. The uptake rate of prenatal diagnosis was assumed to be 100%; the uptake rate for partners of carrier women was assumed to be 100%.
Measure of benefits used in the economic analysis
The outcome measure used for the economic analysis was the number of affected pregnancies detected.
Direct costs
Costs were analysed from the perspective of the health care system and focussed on the cost of the screening process. This included the cost of information giving, DNA testing, genetic counselling, and prenatal diagnosis. Estimates were made for the cost of screening a hypothetical cohort of one million women. The unit cost for each component was reported, with costs taken from the published literature and from an unpublished pilot study. Costs were expressed in 1995 prices. criteria for inclusion were applied to this review. The reliability of the outcome measures used to derive estimates of benefit is therefore uncertain. Differences between the findings of this study and findings from previous studies were considered and analysed.
Validity of estimate of costs
The cost of DNA tests and the inclusion of indirect costs were recognised as explanatory factors for differences in the findings of previous studies. In addition, the proportion of affected pregnancies terminated and the inclusion of just one pregnancy per woman screened increased the cost-effectiveness ratio. The cost of training counsellors was not included in the analysis. The cost of providing counselling may therefore have been underestimated and the cost-effectiveness of the screening programmes may therefore have been overestimated.
